Skip to content

Are nootropics safe? A beginner's safety checklist

In the US, FDA does not approve dietary supplements, including those sold for memory and focus, before they reach the market. Lab tests have found many supplements whose contents did not match the label, and some ingredients sold as nootropics carry liver, heart-rhythm or interaction signals. A doctor or pharmacist can check these against your own medicines.

By the NootropicsWork Editorial Team.

Last reviewed Added to the site 20 studies citedEditorial review: NootropicsWork Editorial TeamEducational, not medical advice

Bottom line

In the US, FDA does not approve dietary supplements, including those sold for memory and focus, before they reach the market [21][22]. Lab tests have found many supplements whose contents did not match the label [1], and some ingredients sold as nootropics carry liver, heart-rhythm or interaction signals [8][10][15]. A doctor or pharmacist can check these against your own medicines.

  • FDA states that under US law it does not have the authority to approve dietary supplements before they are marketed, and firms are responsible for evaluating safety and labeling first [21][22].
  • When the US Drug-Induced Liver Injury Network tested 272 supplement products taken by its liver-injury patients, 51% had contents that did not match the label [1].
  • An analysis of FDA warnings from 2007 through 2016 identified 776 dietary supplements containing hidden, unapproved drug ingredients [5].
  • Using 2004-2013 surveillance data, a national study estimated 23,005 US emergency department visits a year for adverse events linked to dietary supplements [17].
  • In a US survey of adults aged 62 to 85, about 15% were at risk of a potential major drug interaction in 2010-2011, and most of those interacting combinations involved medicines and supplements whose use was increasing [12].

Are nootropics safe?

There is no single answer, because "nootropic" covers many different ingredients sold for focus, memory, mood and sleep. Our guide to what nootropics are explains the term. Whether one product is a sensible choice for one person depends on three separate questions, and this checklist takes them in turn: what is actually in the bottle, what the research says about the ingredient, and how it fits with that person's medicines and health.

NCCIH, part of the US National Institutes of Health, notes that dietary supplements may interact with medications or pose risks for people with certain medical problems or who are going to have surgery [24]. It also notes that "natural" does not always mean "safe" [24].

Nothing on this page is personal advice. It summarizes what regulators and studies report, so that you can take better questions to a clinician. Our disclaimer explains how to use the site.

Start with the basics

Sleep and exercise have their own research on mental performance, and neither comes with a label to check. A meta-analysis of 70 articles covering 147 cognitive tests examined six cognitive domains after short-term total sleep deprivation and found effects ranging from small and nonsignificant for reasoning accuracy to large for lapses in simple attention [19]. A 2025 meta-review of 30 systematic reviews with meta-analyses, covering 383 studies and 18,347 participants, found that a single bout of exercise improved cognitive function with a small-to-medium effect (mean SMD = 0.33) [20]. SMD (standardized mean difference) is a way of comparing effects measured on different scales.

Who checks supplements before they are sold?

Rules differ by country. In the US, NCCIH notes that rules for making and selling supplements are less strict than those for prescription or over-the-counter drugs [24]. In the UK, food supplements are not medicinal products and are regulated as food [25].

In the US, FDA says that under the Dietary Supplement Health and Education Act it does not have the authority to approve dietary supplements before they are marketed [21]. Companies are responsible for evaluating the safety and labeling of their products before marketing, and FDA can take action against an adulterated or misbranded product after it reaches the market [22]. FDA's manufacturing rules require firms to follow current good manufacturing practices that help ensure the identity, purity, quality, strength and composition of supplements [21].

Table: Who reviews supplements before sale, by market (checked November 11, 2026)

MarketWhat the regulator says
USFDA does not have the authority to approve dietary supplements before they are marketed; firms evaluate safety and labeling before marketing [21][22]
UKFood supplements are regulated as food under general food law, and the seller is responsible for making sure they are safe for consumption [25]
CanadaAll natural health products need a product licence before marketing; the label carries an eight-digit NPN, which Health Canada says shows the product was reviewed and approved for safety and efficacy [26]
AustraliaMedicines, medical devices and biologicals that can be supplied in Australia are recorded on the Australian Register of Therapeutic Goods, which has separate parts for registered and listed goods, and each entry gets a unique registration or listing number [27][28]. Not verified as of November 11, 2026: we checked TGA's pages on listed complementary medicines and could not load them, so we could not confirm which supplements are regulated as therapeutic goods or which part of the register they fall under
EUDirective 2002/46/EC sets a harmonized list of vitamins and minerals that may be added to food supplements, and EU countries may ask to be notified when a product is placed on their market [29]

A licence number or a register entry tells you a product passed that country's process. It does not tell you the product suits your health or your medicines.

Step 1: Is the product what the label says?

Label accuracy is the first safety question, because every other check assumes you know what you are taking.

The US Drug-Induced Liver Injury Network tested the contents of 272 supplement products collected from its patients and found 51% were mislabeled, meaning their chemical contents did not match the label [1]. Appearance-enhancement, sexual-performance and weight-loss products were the most often mislabeled [1].

Single-ingredient products vary too. In a lab analysis of commercial melatonin supplements sold in Canada, melatonin content ranged from -83% to +478% of the labeled amount, and lot-to-lot variation within one product reached 465% [2]. A 2025 survey by FDA scientists of 110 melatonin products marketed for children found content ranging from 0% to 667% of the label declaration [3].

One lab study looked at a narrower group of memory products: those whose labels listed drugs not approved in the US. Researchers bought online 10 supplements marketed to improve memory and cognitive function, chosen because their labels listed drugs not approved for human use in the US. They found 5 unapproved drugs across them, several drugs not declared on the label, and inaccurate quantities for 75% (9/12) of the declared amounts [4]. They concluded that the health effects of taking untested combinations of unapproved drugs at unpredictable doses are unknown [4]. Across all supplement types, FDA warnings from 2007 through 2016 identified 776 adulterated products from 146 companies, with 157 containing more than 1 unapproved ingredient [5]. Most were marketed for sexual enhancement, weight loss or muscle building [5].

What third-party testing does and does not cover

A 2019 consensus statement by authors from anti-doping, professional sport and military health organizations, writing about the US market, noted that no regulatory authority conducts or mandates a quality review before dietary supplements are sold, and that third-party certification programs each have their own quality assurance program with varying testing components [6]. NCCIH notes that a manufacturer's use of "standardized", "verified" or "certified" does not necessarily guarantee product quality or consistency [24]. Our guide to third-party testing explains what different seals check.

Regulators can set quality requirements for specific ingredients. Health Canada's ginkgo monograph, for example, requires testing to show the finished product contains no more than 5 ppm of ginkgolic acids [33].

Step 2: Does the ingredient have a safety signal?

Our compound pages carry a safety flag when the sources meet set criteria: a regulator action specific to the compound, human interaction evidence, a harm signal from human data, harm in a defined high-risk group, or quality problems found in market testing. A missing flag never means "safe". Three examples follow; each monograph has the full safety section. Each grade badge below shows the evidence for one benefit outcome, not safety.

Ashwagandha

A case series from Iceland and the US Drug-Induced Liver Injury Network described 5 people with liver injury attributed to ashwagandha-containing supplements, who developed jaundice after a latency of 2-12 weeks [7]. None developed liver failure, and liver tests returned to normal within 1-5 months in four of them [7]. A 2026 scoping review of 13 publications covering 25 patients reported that most recovered after stopping, while severe outcomes included one case of acute liver failure that needed a transplant, and three deaths among patients who already had cirrhosis [8]. Australia's TGA published a safety alert on July 7, 2026 stating that cases of liver injury associated with ashwagandha continue to be reported [31]. NCCIH describes liver injury as rare and says ashwagandha should be avoided during pregnancy [30]. See the ashwagandha monograph.

Alpha-GPC

A South Korean population study of 12,008,977 adults aged 50 or older without prior stroke found that people prescribed alpha-GPC had a higher risk of stroke over 10 years (adjusted hazard ratio 1.43) [9]. This is an observational study of prescription use in older adults, so it shows an association, not cause and effect, and results may not apply to healthy younger adults [9]. The health conditions or symptoms that led people to be prescribed alpha-GPC could also contribute to the association [9]. A later correction fixed swapped diagnostic codes in the methods and did not change the results [9]. See the alpha-GPC monograph.

Omega-3

A meta-analysis of 7 cardiovascular outcome trials covering 81,210 patients found that marine omega-3 supplements were associated with a higher risk of atrial fibrillation, an irregular heart rhythm (HR 1.25), and the hazard ratio was greater in trials testing more than 1 g a day (HR 1.49) than in trials testing 1 g a day or less (HR 1.12) [10]. A separate meta-analysis of 11 randomized trials (120,643 patients) found no overall difference in bleeding compared with control groups (rate ratio 1.09) [11]. In its prespecified analysis of high-dose purified EPA, the relative risk of bleeding was 50% higher than with placebo, although the absolute increase was modest (0.6%) [11]. Both analyses pooled patients rather than healthy volunteers, so results may not apply to healthy adults [10][11]. See the omega-3 monograph, which also covers analyses that differ on the atrial fibrillation finding at lower doses.

Step 3: Could it interact with medicines?

In a nationally representative US sample of adults aged 62 to 85, dietary supplement use rose from 51.8% to 63.7% between 2005-2006 and 2010-2011, and about 15.1% were at risk of a potential major drug interaction in 2010-2011 [12]. Most of those interacting combinations involved medicines and dietary supplements whose use was increasing [12].

Ginkgo biloba

NCCIH reports that ginkgo may increase the risk of bleeding in people taking anticoagulant drugs, such as warfarin [32]. Health Canada's ginkgo monograph says not to use it with blood thinners or other health products that affect blood coagulation, or when having surgery [33]. Laboratory clotting measures from trials of standardized extracts were more reassuring: a meta-analysis of hemostasis measures from 18 randomized controlled trials (1,985 adults, 87% of them patients with clinical conditions) found these measures did not indicate a higher bleeding risk with standardized ginkgo extract [13], and a crossover study in 12 healthy men found ginkgo did not significantly affect clotting status or the action of a single warfarin dose [14]. A meta-analysis of clotting tests, made up mostly of patient trials, and one small study cannot settle the question for every product, so the NCCIH and Health Canada cautions above still stand. See the ginkgo biloba monograph.

Rhodiola rosea

In a randomized crossover study, 13 healthy volunteers took a commercial rhodiola product (Arctic Root) for 14 days and showed a 21% decrease in a marker of the activity of CYP2C9, an enzyme that breaks down some medicines [15]. The authors noted the effect was modest but might matter for medicines with a narrow safe range that use this enzyme, such as phenytoin and warfarin [15]. Health Canada's rhodiola monograph asks people taking antidepressant medication, hormone replacement therapy or birth control medication to consult a practitioner before use, and says not to use it with bipolar disorder [34]. See the rhodiola rosea monograph.

Melatonin

The NHS lists medicines to check with a pharmacist or doctor before taking melatonin, including warfarin and some types of antidepressants, such as fluvoxamine [35]. In the UK, the NHS describes melatonin as a medicine available only with a prescription [35]. Label content also varies widely, as Step 1 showed [2][3]. See the melatonin monograph.

If you take any of these medicines, talk to your doctor or pharmacist before combining them with a supplement. NCCIH also advises telling your health care providers about all supplements well before an operation, because some may increase the risk of bleeding or affect the response to anesthesia [24].

Step 4: Pregnancy, children and health conditions

NCCIH notes that many dietary supplements have not been tested in pregnant women, nursing mothers or children [24]. Several sources on this page name specific cautions: NCCIH says ashwagandha should be avoided during pregnancy [30], NCCIH says ginkgo may be unsafe during pregnancy [32], the NHS says melatonin is not usually used during pregnancy [35], and Health Canada's rhodiola monograph asks people who are pregnant or breastfeeding to consult a practitioner first [34].

Children can also be harmed by supplements kept at home. US poison centers received reports of 260,435 melatonin ingestions by children and teenagers from 2012 to 2021, with the annual number up 530%; five children needed mechanical ventilation and two died [16]. The rise in hospitalizations and more serious outcomes was mainly due to unintentional ingestions by children aged 5 or under [16]. UK labeling rules require food supplements to carry a statement that they should be stored out of the reach of young children [25].

Step 5: Know how problems show up and how to report them

Using surveillance data from 63 US emergency departments from 2004 through 2013, a national study estimated 23,005 emergency department visits a year nationwide for adverse events related to dietary supplements, leading to an estimated 2,154 hospitalizations [17]. Weight-loss or energy products caused 71.8% of the supplement-related adverse events involving palpitations, chest pain or a fast heart rate [17]. In the US Drug-Induced Liver Injury Network, the share of liver injury cases caused by herbal and dietary supplements rose from 7% to 20% between 2004 and 2013 [18].

FDA lists signs of a serious reaction that include rash, hives or swelling of the throat, lips or tongue; fainting, chest pain or an irregular heartbeat; severe, persistent nausea or abdominal pain; and marked changes in mood or behavior [23]. FDA advises anyone who thinks a supplement caused a serious reaction or illness to stop using the product and file a report through the Safety Reporting Portal [23]. NCCIH advises that people with side effects stop the supplement and contact their health care provider [24].

What doesn't have good evidence

Several common beliefs about supplement safety do not hold up against the sources on this page.

  • "Natural means safe." NCCIH says "natural" does not always mean "safe" [24], and the liver injury reports for ashwagandha involve herbal supplements [7][8].
  • "If a shop sells it, a regulator approved it." In the US, FDA does not approve supplements before they are marketed [21], and products have reached the market with undeclared drug ingredients [4][5].
  • "A 'verified' or 'standardized' label guarantees quality." NCCIH says these terms do not necessarily guarantee quality or consistency [24], and third-party programs differ in what they test [6].
  • "A certification seal means the product works." Certification programs review quality and contents [6]. Whether an ingredient does anything is a separate question, which our grades answer one outcome at a time.

How to read these grades

The grade badges above come from our evidence matrix and show the evidence for one outcome, not safety. A strong grade for a benefit says nothing about interactions or label accuracy, and the safety flag is shown separately on each monograph. The rubric is on how we grade evidence.

FAQ

Are nootropics regulated?

In the US, FDA does not have the authority to approve dietary supplements before they are marketed, and firms are responsible for safety and labeling first [21][22]. Canada requires a product licence before a natural health product is marketed [26], and the UK regulates food supplements as food [25].

Can nootropic supplements contain hidden drugs?

Yes, in some tested products. A lab study of 10 supplements marketed for memory and cognitive function, chosen because their labels listed drugs not approved in the US, found 5 unapproved drugs, several of them not declared on the label [4], and across all supplement types, FDA warnings from 2007 through 2016 identified 776 adulterated products, most marketed for sexual enhancement, weight loss or muscle building [5].

Do nootropics interact with medications?

Some ingredients do. A study in healthy volunteers found rhodiola reduced the activity of CYP2C9, an enzyme that breaks down some medicines, including warfarin and phenytoin [15], and Health Canada says not to use ginkgo with blood thinners [33]. A doctor or pharmacist can check a specific combination.

Does third-party testing make a supplement safe?

Third-party programs review product quality, but each has its own testing components [6]. A seal says nothing about whether the ingredient suits your health or interacts with your medicines.

Grades in this guide

Grades come from the evidence matrix and update with it.

References

  1. Navarro V, Avula B, Khan I, et al. The Contents of Herbal and Dietary Supplements Implicated in Liver Injury in the United States Are Frequently Mislabeled. Hepatol Commun. 2019.PMID 31168513DOI 10.1002/hep4.1346Tier 1
  2. Erland LA, Saxena PK. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content. J Clin Sleep Med. 2017.PMID 27855744DOI 10.5664/jcsm.6462Tier 1
  3. Pawar RS, Coppin JP, Khanna S, et al. A Survey of Melatonin in Dietary Supplement Products Sold in the United States. Drug Test Anal. 2025.PMID 39482109DOI 10.1002/dta.3823Tier 1
  4. Cohen PA, Avula B, Wang YH, et al. Five Unapproved Drugs Found in Cognitive Enhancement Supplements. Neurol Clin Pract. 2021.PMID 34484905DOI 10.1212/CPJ.0000000000000960Tier 1
  5. Tucker J, Fischer T, Upjohn L, et al. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. JAMA Netw Open. 2018.PMID 30646238DOI 10.1001/jamanetworkopen.2018.3337Tier 1
  6. Eichner AK, Coyles J, Fedoruk M, et al. Essential Features of Third-Party Certification Programs for Dietary Supplements: A Consensus Statement. Curr Sports Med Rep. 2019.PMID 31082891DOI 10.1249/JSR.0000000000000595Tier 1
  7. Björnsson HK, Björnsson ES, Avula B, et al. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020.PMID 31991029DOI 10.1111/liv.14393Tier 1
  8. McIntyre D, Nguyen P, Kim Y, et al. Ashwagandha (Withania somnifera)-Associated Liver Injury: A Scoping Review of Clinical Characteristics and Safety Considerations. Cureus. 2026.PMID 42367407DOI 10.7759/cureus.109764Tier 1, narrative review
  9. Lee G, Choi S, Chang J, et al. Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. JAMA Netw Open. 2021.PMID 34817582DOI 10.1001/jamanetworkopen.2021.36008Tier 1
  10. Gencer B, Djousse L, Al-Ramady OT, et al. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulation. 2021.PMID 34612056DOI 10.1161/CIRCULATIONAHA.121.055654Tier 1, meta-analysis
  11. Javaid M, Kadhim K, Bawamia B, et al. Bleeding Risk in Patients Receiving Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Am Heart Assoc. 2024.PMID 38742535DOI 10.1161/JAHA.123.032390Tier 1, meta-analysis
  12. Qato DM, Wilder J, Schumm LP, et al. Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016.PMID 26998708DOI 10.1001/jamainternmed.2015.8581Tier 1
  13. Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011.PMID 21923430DOI 10.1592/phco.31.5.490Tier 1, meta-analysis
  14. Jiang X, Williams KM, Liauw WS, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2005.PMID 15801937DOI 10.1111/j.1365-2125.2005.02322.xTier 1, RCT
  15. Thu OK, Spigset O, Nilsen OG, et al. Effect of commercial Rhodiola rosea on CYP enzyme activity in humans. Eur J Clin Pharmacol. 2016.PMID 26613955DOI 10.1007/s00228-015-1988-7Tier 1, RCT
  16. Lelak K, Vohra V, Neuman MI, et al. Pediatric Melatonin Ingestions - United States, 2012-2021. MMWR Morb Mortal Wkly Rep. 2022.PMID 35653284DOI 10.15585/mmwr.mm7122a1Tier 1
  17. Geller AI, Shehab N, Weidle NJ, et al. Emergency Department Visits for Adverse Events Related to Dietary Supplements. N Engl J Med. 2015.PMID 26465986DOI 10.1056/NEJMsa1504267Tier 1
  18. Navarro VJ, Barnhart H, Bonkovsky HL, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014.PMID 25043597DOI 10.1002/hep.27317Tier 1
  19. Lim J, Dinges DF. A meta-analysis of the impact of short-term sleep deprivation on cognitive variables. Psychol Bull. 2010.PMID 20438143DOI 10.1037/a0018883Tier 1, meta-analysis
  20. Chang YK, Ren FF, Li RH, et al. Effects of acute exercise on cognitive function: A meta-review of 30 systematic reviews with meta-analyses. Psychol Bull. 2025.PMID 39883421DOI 10.1037/bul0000460Tier 1, meta-analysis
  21. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. Updated August 27, 2026.SourceTier 1
  22. U.S. Food and Drug Administration. Dietary Supplements. Updated October 1, 2024.SourceTier 1
  23. U.S. Food and Drug Administration. How to Report a Problem with Dietary Supplements. Updated March 13, 2025.SourceTier 1
  24. National Center for Complementary and Integrative Health (NIH). Using Dietary Supplements Wisely. 2019-01 (Last Updated: January 2019).SourceTier 2
  25. UK Government (GOV.UK). Food supplements: guidance for businesses. Updated July 2, 2018.SourceTier 1
  26. Health Canada. Product Licensing (natural health products). Updated May 4, 2017.SourceTier 1
  27. Therapeutic Goods Administration. Australian Register of Therapeutic Goods (ARTG). not shown in fetched text.SourceTier 1
  28. Federal Register of Legislation (Australian Government). Therapeutic Goods Act 1989, Compilation No. 89. Compilation No. 89, compilation date 5 September 2025 (served as the latest version on 2026-11-11).SourceTier 1
  29. European Commission. Food supplements. not shown in fetched text.SourceTier 1
  30. National Center for Complementary and Integrative Health (NIH). Ashwagandha: Usefulness and Safety. 2023-03 (Last Updated: March 2023).SourceTier 2
  31. Therapeutic Goods Administration (Australian Government). Herbal preparations containing Withania somnifera (Withania, Ashwagandha): safety alert. Updated July 7, 2026.SourceTier 1
  32. National Center for Complementary and Integrative Health (NIH). Ginkgo: Usefulness and Safety. 2025-02 (Last Updated: February 2025).SourceTier 2
  33. Health Canada, Natural and Non-prescription Health Products Directorate. Ginkgo - Ginkgo biloba (NHPID monograph). Updated July 25, 2025.SourceTier 1
  34. Health Canada, Natural and Non-prescription Health Products Directorate. Rhodiola - Rhodiola rosea (NHPID single ingredient monograph). Updated October 31, 2025.SourceTier 1
  35. NHS. Melatonin: a medicine used for sleep problems. Updated November 6, 2026.SourceTier 2
Reviewed by NootropicsWork Editorial Team, editorial team. Checklist logged . Next review due . Report an error